Review

Resveratrol and Diabetes

Natalia G. Vallianou¹, Angelos Evangelopoulos², Christos Kazazis³

Manuscript submitted December 1, 2013; resubmitted December 11, 2013; accepted December 12, 2013.

Keywords: diabetes, FOXO1, glucose transport, GLUT4, mitochondrial function, AMPK, SIRT1, resveratrol

Abstract

Resveratrol is a stilbene compound, and a phytoalexin, synthesized by plants in response to stressful stimuli, usually caused by infection. It is abundantly present in red wine, ports and sherries, red grapes, blueberries, peanuts, itadori tea, as well as hops, pistachios, and in grape and cranberry juices. The anti-hyperglycemic effects of resveratrol seem to be the result of an increased action of the glucose transporter in the cytoplasmic membrane. Studies on rats with streptozotocin-induced diabetes have demonstrated that the expression of the insulin-dependent glucose transporter, GLUT4, is increased after resveratrol ingestion. Also, resveratrol enhances adiponectin levels, which could be one of the potential mechanisms by which it improves insulin sensitivity. Another important observation is that resveratrol induces the secretion of the gut incretin hormone, glucagon-like peptide-1. Resveratrol is also reported to activate Sir2 (silent information regulatory 2), a SIRT1 homolog, thus mimicking the benefits of calorie restriction. It produces a wide variety of effects in mammalian cells, including activation of AMP-activated protein kinase, which is involved in some of the same metabolic pathways as SIRT1, which may influence other mechanisms via the involvement of nuclear factor kappa B (NF-κB). In the near future, resveratrol-based therapies with either resveratrol or its analogs that have better bioavailability could be useful in the treatment of diabetes and its complications, either alone or in combination with other anti-diabetic drugs.

Fulltext: HTML , PDF (138KB)

This article has been cited by other articles:

	The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis Zare Javid A, Hormoznejad R, Yousefimanesh HA, Zakerkish M, Haghighi-Zadeh MH, Dehghan P, Ravanbakhsh M Phytother Res 2017. 31(1):108-114
	Intake of Total Polyphenols and Some Classes of Polyphenols Is Inversely Associated with Diabetes in Elderly People at High Cardiovascular Disease Risk Tresserra-Rimbau A, Guasch-Ferre M, Salas-Salvado J, Toledo E, Corella D, Castaner O, Guo X, Gomez-Gracia E, Lapetra J, Aros F, Fiol M, Ros E, Serra-Majem L, Pinto X, Fito M, Babio N, Martinez-Gonzalez MA, Sorli JV, Lopez-Sabater MC, Estruch R, Lamuela-Raventos RM, PREDIMED study investigators J Nutr 2016. In press
	Resveratrol Prevents Retinal Dysfunction by Regulating Glutamate Transporters, Glutamine Synthetase Expression and Activity in Diabetic Retina Zeng K, Yang N, Wang D, Li S, Ming J, Wang J, Yu X, Song Y, Zhou X, Yang Y Neurochem Res 2016. 41(5):1050-1064
	Resveratrol Inhibits Diabetic-Induced Müller Cells Apoptosis through MicroRNA-29b/Specificity Protein 1 Pathway Zeng K, Wang Y, Yang N, Wang D, Li S, Ming J, Wang J, Yu X, Song Y, Zhou X, Deng B, Wu X, Huang L, Yang Y Mol Neurobiol 2016. In press
	Effects of Resveratrol on Receptor for Advanced Glycation End Products (RAGE) Expression and Oxidative Stress in the Liver of Rats with Type 2 Diabetes Khazaei M, Karimi J, Sheikh N, Goodarzi MT, Saidijam M, Khodadadi I, Moridi H Phytother Res 2016. 30(1):66-71
	The Effect of Resveratrol Supplementation in Adjunct with Non-surgical Periodontal Treatment on Blood Glucose, Triglyceride, Periodontal Status and Some Inflammatory Markers in Type 2 Diabetic Patients with Periodontal Disease Javid AZ, Hormoznejad R, Yousefimanesh H, Zakerkish M, Haghighi-zadeh MH, Barzegar A, Niknejad N Nutr Food Sci Res 2016. 3(1):17-26
	Anti-apoptotic and Beneficial Metabolic Activities of Resveratrol in Type II Gaucher Disease Yoo S, Kim JB Biol Pharm Bull 2015. 38(6):913-918
	Resveratrol-Dependent Down-regulation of Receptor for Advanced Glycation End-products and Oxidative Stress in Kidney of Rats With Diabetes Moridi H, Karimi J, Sheikh N, Goodarzi MT, Saidijam M, Yadegarazari R, Khazaei M, Khodadadi I, Tavilani H, Piri H, Asadi S, Zarei S, Rezaei A Int J Endocrinol Metab 2015. 13(2):e23542
	Therapeutic Potential of Resveratrol in Type I Gaucher Disease Seo CH, Kim JB Phytother Res 2015. In press
	Therapeutic potential of resveratrol for the treatment of type III Gaucher disease Yoo S, Kim JB Neurol Asia 2015. 20(1):43-48